A carregar...
An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19
SARS-CoV-2 is the viral pathogen causing the COVID19 global pandemic. Consequently, much research has gone into the development of pre-clinical assays for the discovery of new or repurposing of FDA-approved therapies. Preventing viral entry into a host cell would be an effective antiviral strategy....
Na minha lista:
| Publicado no: | bioRxiv |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cold Spring Harbor Laboratory
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7315994/ https://ncbi.nlm.nih.gov/pubmed/32596694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.06.23.167544 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|